Back
Apellis Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$22.81
Seasonality Move:
5.14%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.26 | Buy |
| 20-day SMA: | 22.48 | Buy |
| 50-day SMA: | 23.43 | Sell |
| 200-day SMA: | 22.22 | Buy |
| 8-day EMA: | 22.33 | Buy |
| 20-day EMA: | 22.49 | Buy |
| 50-day EMA: | 22.82 | Sell |
| 200-day EMA: | 23.86 | Sell |
Apellis Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 51.38 | Buy |
| Chaikin Money Flow: | 2010134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.1 - 23.04) | Buy |
| Bollinger Bands (100): | (20.61 - 25.73) | Sell |
Apellis Pharmaceuticals, Inc. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals, Inc. Stock
Is Apellis Pharmaceuticals, Inc. Stock a Buy?
-
Apellis Pharmaceuticals, Inc. share price is 22.80 while APLS 8-day simple moving average is 22.26, which is a Buy signal.
-
The stock price of APLS is 22.80 while Apellis Pharmaceuticals, Inc. 20-day SMA is 22.48, which makes it a Buy.
-
Apellis Pharmaceuticals, Inc. 50-day simple moving average is 23.43 while APLS share price is 22.80, making it a Sell technically.
-
APLS stock price is 22.80 and Apellis Pharmaceuticals, Inc. 200-day simple moving average is 22.22, creating a Buy signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
48
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. a Buy or a Sell?
-
Apellis Pharmaceuticals, Inc. stock is rated a SellThe current Apellis Pharmaceuticals, Inc. [APLS] share price is $22.80. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals, Inc. Stock Info
Market Cap:
2.9B
Price in USD:
22.80
Share Volume:
2M
Apellis Pharmaceuticals, Inc. 52-Week Range
52-Week High:
30.48
52-Week Low:
16.10
Sell
48
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Apellis Pharmaceuticals, Inc. Share Price Forecast
-
What is the Apellis Pharmaceuticals, Inc. stock price today?The Apellis Pharmaceuticals, Inc. stock price is 22.80 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals, Inc. is overvalued.
Is Apellis Pharmaceuticals, Inc. Stock a Buy?
-
Apellis Pharmaceuticals, Inc. share price is 22.80 while APLS 8-day exponential moving average is 22.33, which is a Buy signal.
-
The stock price of APLS is 22.80 while Apellis Pharmaceuticals, Inc. 20-day EMA is 22.49, which makes it a Buy.
-
Apellis Pharmaceuticals, Inc. 50-day exponential moving average is 22.82 while APLS share price is 22.80, making it a Sell technically.
-
APLS stock price is 22.80 and Apellis Pharmaceuticals, Inc. 200-day simple moving average is 23.86, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals, Inc.
Is Apellis Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.89 per share.
Technical Analysis of Apellis Pharmaceuticals, Inc.
Should I short Apellis Pharmaceuticals, Inc. stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Apellis Pharmaceuticals, Inc. is a Sell
-
Apellis Pharmaceuticals, Inc. Relative Strength Index (RSI) is 51.38, which suggest Apellis Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals, Inc. is (21.1 - 23.04), which suggest Apellis Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals, Inc. is (20.61 - 25.73), which suggest Apellis Pharmaceuticals, Inc. is a Sell
* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.